FDA Exploring Over-the-Counter Access to Vaginal Estrogen
The FDA says it is working with sponsors to explore over-the-counter availability of vaginal estrogen. Here’s what that could mean for vaginal dryness and other menopause symptoms.
The FDA says it is working with sponsors to explore over-the-counter availability of vaginal estrogen. Here’s what that could mean for vaginal dryness and other menopause symptoms.
An executive order signed October 19, 2026 creates a Women’s Health Division at NIH and a White House Women’s Health Task Force, and names menopause among the areas needing more research.
ACOG issued its most comprehensive menopause guidance yet, strongly recommending hormone therapy for hot flashes and sleep problems and expanding advice on nonhormonal treatments, mood and sleep.
The American College of Physicians issued a new guideline recommending estrogen-based hormone therapy as first-line treatment for menopausal hot flashes and night sweats, with ranked nonhormonal alternatives.
The FDA held a public workshop on testosterone use in menopausal women. No testosterone product is approved for women, and the comment period has closed. Here’s what was discussed and what comes next.
Black women are navigating menopause with less support, more symptoms, and higher rates of medical dismissal — and now we finally have the data to prove it. The Black Women’s Health Imperative has released the largest U.S. survey ever conducted on Black women’s menopause experiences, uncovering major gaps in care, information, and equity. Here’s what the findings reveal — and why this research matters for every woman in midlife.
For over 20 years, low-dose vaginal estrogen has carried a frightening FDA black box warning—despite no evidence of the risks it lists. Experts now say this outdated label is keeping women from a safe, effective treatment for painful and life-altering menopause symptoms.